The Forward P/E of Cell Source Inc (CLCS) is N/A.
Forward P/E estimates how much investors are willing to pay today for each dollar of a company's expected future earnings. It serves as a valuation tool based on projected profitability rather than past performance.
Ticker | Name | Value |
---|---|---|
SBFM | Sunshine Biopharma Inc | 1.97 |
OCUP | Ocuphire Pharma Inc | 9.27 |
PHIO | Phio Pharmaceuticals Corp | 0.42 |